Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

347 ARTÍCULOS , VIENDO DEL 151 AL 165

The immunopathogenic role of reactive oxygen species in Alzheimer disease

Mohsenzadegan M, Mirshafiey A.

Iran J Allergy Asthma Immunol. 2012 Sep;11(3):203-16.

Treatment strategies targeting amyloid β-protein

Schenk D, Basi GS, Pangalos MN.

Cold Spring Harb Perspect Med. 2012 Sep 1;2(9):a006387. doi: 10.1101/cshperspect.a006387.

Effect of some medicinal plant extracts on the oxidative stress status in Alzheimer's disease induced in rats

Mahdy K, Shaker O, Wafay H, Nassar Y, Hassan H, Hussein A.

Eur Rev Med Pharmacol Sci. 2012 Jul;16 Suppl 3:31-42.

The potential protective effect of tramiprosate (homotaurine) against Alzheimer's disease: a review

Caltagirone C, Ferrannini L, Marchionni N, Nappi G, Scapagnini G, Trabucchi M.

Aging Clin Exp Res. 2012 Dec;24(6):580-7. doi: 10.3275/8585. Epub 2012 Sep 5.

Mitochondrial oxidative stress index, activity of redox-sensitive aconitase and effects of endogenous anti- and pro-oxidants on its activity in control, Alzheimer's disease and Swedish Familial Alzheimer's disease brain

Raukas M, Rebane R, Mahlapuu R, Jefremov V, Zilmer K, Karelson E, Bogdanovic N, Zilmer M.

Free Radic Res. 2012 Dec;46(12):1490-5. doi: 10.3109/10715762.2012.728286. Epub 2012 Sep 27.

The future dominance of combination therapies: implications for today's medical research

de Grey AD.

Rejuvenation Res. 2012 Oct;15(5):443-4. doi: 10.1089/rej.2012.1376.

Concise review: Can stem cells be used to treat or model Alzheimer's disease?

Chen WW, Blurton-Jones M.

Stem Cells. 2012 Dec;30(12):2612-8. doi: 10.1002/stem.1240.

Animal models of Alzheimer disease

LaFerla FM, Green KN.

Cold Spring Harb Perspect Med. 2012 Nov 1;2(11):a006320. doi: 10.1101/cshperspect.a006320.

Response to rivastigmine transdermal patch or memantine plus rivastigmine patch is affected by apolipoprotein E genotype in Alzheimer patients

Han HJ, Kim BC, Lee JY, Ryu SH, Na HR, Yoon SJ, Park HY, Shin JH, Cho SJ, Yi HA, Choi MS, Heo JH, Park KW, Kim KK, Choi SH.

Dement Geriatr Cogn Disord. 2012;34(3-4):167-73. doi: 10.1159/000342927. Epub 2012 Oct 5.

Rivastigmine dermal patch solves eating problems in an individual with advanced Alzheimer's disease

Uwano C, Suzuki M, Aikawa T, Ebihara T, Une K, Tomita N, Kosaka Y, Okinaga S, Furukawa K, Arai H, Ohrui T.

J Am Geriatr Soc. 2012 Oct;60(10):1979-80. doi: 10.1111/j.1532-5415.2012.04182.x.

Alzheimer disease: what new evidence shows

Uriri-Glover J, McCarthy M, Cesarotti E.

Nurs Manage. 2012 Nov;43(11):26-31; quiz 31-2. doi: 10.1097/01.NUMA.0000421671.10723.ad.

Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress

Castellani RJ, Perry G.

Arch Med Res. 2012 Nov;43(8):694-8. doi: 10.1016/j.arcmed.2012.09.009. Epub 2012 Oct 16.

Drug repositioning for Alzheimer's disease

Corbett A, Pickett J, Burns A, Corcoran J, Dunnett SB, Edison P, Hagan JJ, Holmes C, Jones E, Katona C, Kearns I, Kehoe P, Mudher A, Passmore A, Shepherd N, Walsh F, Ballard C.

Nat Rev Drug Discov. 2012 Nov;11(11):833-46. doi: 10.1038/nrd3869.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias